CATIE exmined the benefits versus risks of second versus first generation antipsychotics, but there is still confusion as to how to implement the findings into clinical practice. By better understanding the results/findings of the CATIE study, clinicians will be better able to choose the appropriate antipsychotics for their patients; monitor side effects and determine when switching is appropriate; choose an alternative antipsychotic for each patient on a case by case basis; and balance side effects and patient concedrns with treatment efficacy.

CME, 1.5 Credits    Jan 15, 2010

This CME article discusses the pathogenesis of early-onset schizophrenia-spectrum disorders, treatment options for children and adolescents, and benefits versus adverse effects of atypical antipsychotics.

CME, 1.5 Credits    Aug 01, 2009

This activity discusses the differences in symptoms of schizophrenia versus schizoaffective disorder. Individualizing treatment plans as well as factors that contribute to treatment nonadherence will also be discussed.

CME, 1.5 Credits    Apr 15, 2009

CME, 27.25 Credits    Oct 01, 2008